Opinion

Video

Closing Thoughts From The Panel On Pneumococcal Vaccination

Author(s):

Christina M. Madison, PharmD, FCCP, AAHIVP,Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP

The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.

Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
Pneumococcal vaccine bottles and syringes for preventing pneumonia.
April 2nd 2025

Single Dose of PCV20 for Toddlers Following Previous PCV13 Doses Protects Against Additional Pneumococcal Serotypes

Luke Halpern, Assistant Editor
Socioeconomic Inequities Have a Significant Impact on Treatment of Antimicrobial Resistant Infections
January 28th 2025

Socioeconomic Inequities Have a Significant Impact on Treatment of Antimicrobial Resistant Infections

Camille Cabas, PharmD
Pneumococcal Vaccine, Vaccine Hesitancy, Pneumonia, Immunization | Image Credit: © PRO Balance | stock.adobe.com
December 27th 2024

Collective Responsibility, Confidence in Immunizations Indicate Potential of Vaccine Refusal

Ashley Gallagher, Editor
When to Call, When to Counsel: Fluoroquinolone Tendinopathy
December 17th 2024

When to Call, When to Counsel: Fluoroquinolone Tendinopathy

K. Ashley Garling, PharmD RahJewel Barnhill, PharmD Candidate
Pneumonia, CAP, Biomarkers, Pneumococcal | Image Credit: © SOPONE | stock.adobe.com
December 16th 2024

Two Biomarkers Improve CRB-65 Predictability for Death Due to Community-Acquired Pneumonia

Ashley Gallagher, Editor
Research Reveals Opportunities for Antimicrobial Stewardship When Treating Community-Acquired Pneumonia
December 10th 2024

Research Reveals Opportunities for Antimicrobial Stewardship When Treating Community-Acquired Pneumonia

Aislinn Antrim, Managing Editor